# EKTERLY

NDC: 82928-300
Generic name: sebetralstat
Labeler / Manufacturer: KalVista Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250707

FDA application: NDA219301

## Active ingredients

- SEBETRALSTAT: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82928-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82928-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d145e2f-8e7e-2e90-e063-6294a90a4449
